Effect of Donepezil on Smoking

NCT01250977 PHASE2 COMPLETED Results posted

The objective of this proof-of-concept pilot study is to evaluate Donepezil HCL (Aricept) for side effects and effects on smoking behavior and performance on neurocognitive tasks in a population of dependent smokers.

Details

Lead sponsor	Abramson Cancer Center at Penn Medicine
Phase	PHASE2
Status	COMPLETED
Enrolment	30
Start date	Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Smoking

Interventions

• Donepezil
• Placebo

Countries

United States